Riga Health Conference – Universal health: Investing in Health and Wellbeing for All
June 29th - 30th, 2015
J Radison BLU Hotel Latvija, Riga, Latvia
Partner Event: MPNE 2015 – The risk of not taking risks in melanoma
April 24th - 26th
HOTEL MARIVAUX BRUSSELS, Boulevard Adolphe Max 98, 1000 Brussels - Belgium
Webinar: MAPPs – New Tools for Decision Making
April 14th, 2:00 pm - 3:00 pm CEST
What is the current status of MAPPs in Europe and the US?
DIA EuroMeeting 2015| Palais des Congrès | Paris
April 13th -15th, 2015 - Theme 9 - Big Data, Mobile Health
Harnessing Big Data to make better, quicker medical decisions is a logical development. However, this demands a delicate balance between individual patient rights and the wider public good. This theme explores how to reconcile these issues to maximise the benefits offered by harnessing available health data. How can Big Data improve patient outcomes and accelerate clinical development? What are the implications of data ownership, and what will be the role of social media in healthcare?
WEBINAR: Stem Cells, Gene Therapies, and Tissue Engineering: How do we Put Advanced Therapies into Practice in Europe?
March 16th, 2015, 2-3pm CET Therapies into Practice
21st Century Cures Moves Towards Development of MAPPs Infrastructures and Methodologies
Feb 6th, 2015 - by Magda Chlebus While Europe is leading in the development of tools and methodologies in Medicine’s Adaptive Pathways (MAPPs) through the EMA live pilots and upcoming projects in IMI2, the key bottlenecks still holding back its implementation in Europe are gaining traction with the United States congress. This situation illustrates our need in Europe to move quickly and develop implementation strategies and foster political support for MAPPs whilst we still hold the drive and initiative.
Independent report points the way forward for the responsible sharing of clinical trial data
Jan 15th, 2015 A new culture is needed to promote the equitable and open sharing of data, to advance science, whilst protecting the interests of all stakeholders, says the US Institute of Medicine The sharing of clinical trials data is clearly in the public interest, but huge effort is required to develop the policies and put in place the technical infrastructure and create a culture of openness, according to a new report from the US Institute of Medicine (IOM).
Conference Report: Digital Health – Catapulting Personalised Medicine Forward
Dec 12th, 2014 - by Nuala MoranIn a ground-breaking collaboration, The UK’s Digital Catapult, The Fellowship of Post Graduate Medicine, IDEALondon, and Vital Transformation brought together the best and brightest minds in Europe working at the frontiers of research where Personalised Medicines and Health Technologies intersect. This round table demonstrated how next-generation technologies and social media will integrate with public health, thus facilitating the burgeoning market for personalised medicines. The sessions included disruptive start-ups and technology savvy practitioners finding common ground in the desire to bring stratified medicines to patients.
Digital Health: Catapulting Personalised Medicine Forward
November 27th, 2014 - Connected Digital Economy Catapult, London
This round table will feature demonstrations of how next-generation technologies and social media will integrate with public health, thus facilitating the burgeoning market for personalised medicines. The session will include disruptive start-ups and technology savvy practitioners finding common ground in the desire to bring stratified medicines to patients.
This event is organised in collaboration with:
WEBINAR: What are Medicine’s Adaptive Pathway’s to Patients (MAPPs)?
December 11th, 2pm - 3:30 PM CET This webinar updated EFPIA members on Medicines Adaptive Pathways to Patients (MAPPs) and its potential impact on research, development, licensing, HTA, and pricing & reimbursement in relation to early patient access.